Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Cardiology

Common Clinical Patterns and Diagnosis

At a Glance

Atrial fibrillation may occur in brief episodes or continue for weeks or months, and its pattern can change over time. Doctors combine a heart tracing or longer-term monitor with heart imaging and tests for thyroid problems or sleep apnea to confirm AFib and guide care.

Atrial Fibrillation is not a “one-size-fits-all” condition. It often begins as short, infrequent episodes that may go unnoticed, but it has a natural tendency to evolve. Doctors use specific categories to describe how long your episodes last and how much the disease has progressed. Understanding these clinical patterns is vital because they often dictate which treatments will be most effective for you.

Common Clinical Patterns of AFib

Clinical guidelines categorize AFib based on the duration and frequency of the episodes [1]. It is important to know that these are not inevitable fixed stages, but clinical patterns that help guide care.

  1. First Diagnosed AFib: AFib that has not been previously diagnosed, regardless of the duration of the current episode or severity of symptoms.
  2. Paroxysmal AFib: These are episodes that start suddenly and stop on their own, or with medical help, within seven days [1][2]. Many patients find these episodes last only a few minutes or hours.
  3. Persistent AFib: This describes AFib that lasts longer than seven days continuously [1][3]. These episodes usually require a medical intervention, such as a medication or an electrical “shock” (cardioversion), to return the heart to a normal rhythm.
  4. Long-Standing Persistent AFib: This is a more advanced pattern where the heart has been in a continuous state of AFib for more than 12 months, but your care team is still actively trying to restore a normal rhythm [4][5].
  5. Permanent AFib: This is not a measure of time or tissue damage, but a shared decision between you and your doctor. It means that you both have decided to stop trying to restore a normal rhythm and will instead focus on managing your heart rate and preventing stroke [6].

“AFib Begets AFib”: Why Early Action Matters

There is a well-known concept in cardiology that “AFib begets AFib” [7]. This means that the longer your heart stays in an irregular rhythm, the more the heart tissue changes to accommodate that rhythm.

  • Electrical Short-Circuiting: As AFib persists, the heart’s cells begin to “remodel” their electrical properties, making it easier for chaotic signals to travel and harder for a normal rhythm to take hold [8][9].
  • Structural Scarring: Over time, the constant irregular beating can lead to fibrosis (scarring) and stretching of the atria [10][11]. This physical damage acts like a permanent “detour” for electricity, making future treatments—like ablation—less likely to succeed if the disease is allowed to progress for years [1].

Tools for Detection and Diagnosis

Because AFib can be intermittent, a single 12-lead Electrocardiogram (ECG) in the doctor’s office might miss it. To “catch” the rhythm, your doctor may use several different tools:

  • Holter Monitor: A portable device worn for 24 to 48 hours to record every heartbeat [12].
  • Patch Monitors: Adhesive monitors worn for up to 14 days. These are significantly more effective than standard Holters at detecting intermittent (paroxysmal) AFib [13][14].
  • Implantable Loop Recorder (ILR): A tiny device placed under the skin that can monitor your heart rhythm for up to three years. These are often used for patients who have had unexplained strokes or very infrequent symptoms [15][16].
  • Consumer Wearables: Smartwatches and handheld ECG devices are increasingly used to screen for AFib. While some advanced algorithms report high predictive values depending on the device and population, they are not a replacement for a clinical diagnosis. Any “irregular rhythm notification” from a watch must be confirmed by a medical professional using an appropriate clinical ECG [17][18].

Commonly Recommended Workup

When you are first diagnosed, your doctor must look “under the hood” to see how the AFib has affected your heart’s structure and to find potential triggers. The workup is individualized, but commonly includes:

  • Transthoracic Echocardiogram (TTE): This is an ultrasound of your heart. It is a commonly recommended test for newly diagnosed patients [19]. It checks your Left Atrial Volume Index (LAVI) to see if the chamber is enlarged and measures your Ejection Fraction (EF) to ensure your heart is pumping effectively [20][21].
  • Thyroid Testing (TSH): Overactive thyroid glands are a known trigger for AFib, and checking these hormone levels, along with metabolic and renal testing, is a standard part of the initial workup [22][23].
  • Sleep Apnea Evaluation: Obstructive sleep apnea is highly prevalent in AFib populations [24]. Because it is a major contributor to AFib, your doctor may order a sleep study based on your sleep-apnea risk and symptoms, especially if you are considering a procedure to fix your rhythm [25].

Common questions in this guide

What are the different patterns of atrial fibrillation?
Doctors describe AFib as first diagnosed, paroxysmal, persistent, long-standing persistent, or permanent. These labels mainly reflect how long the irregular rhythm lasts and whether the care team is still trying to restore a normal rhythm; they are not necessarily fixed stages that every person passes through.
How is paroxysmal AFib different from persistent AFib?
Paroxysmal AFib starts and stops within seven days, often without treatment. Persistent AFib continues for more than seven days and usually needs medication or an electrical cardioversion to restore a normal rhythm.
Can a regular office ECG miss atrial fibrillation?
Yes. A standard ECG records only a short period, so it may not capture AFib that happens intermittently. A Holter monitor, adhesive patch monitor, or implantable loop recorder can record the rhythm for much longer.
Can my smartwatch diagnose AFib?
A smartwatch or handheld ECG device can screen for an irregular rhythm, including when you do not feel symptoms. An alert is not a diagnosis and should be confirmed by a medical professional with an appropriate clinical ECG.
What tests are commonly included in a new AFib workup?
The evaluation often includes an echocardiogram to assess heart pumping function and the size of the left atrium, along with thyroid, metabolic, and kidney-related blood tests. Your clinician may also recommend a sleep study when symptoms or risk factors suggest obstructive sleep apnea.
Does AFib become harder to treat if it continues for a long time?
Longer-lasting AFib can change the heart’s electrical behavior and may lead to stretching or scarring of the atria. These changes can make it more difficult for treatments such as ablation to restore and maintain a normal rhythm, so timely evaluation is important.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific clinical pattern of AFib do I have—paroxysmal, persistent, or long-standing persistent?
  2. 2.What did my echocardiogram show regarding my left atrial size and volume (LAVI)?
  3. 3.Is there evidence of 'structural remodeling' in my heart, and does that change how aggressively we should treat my rhythm?
  4. 4.Should I use a wearable device to track my AFib, and how should I report those results to you?
  5. 5.Do we need to investigate underlying causes like sleep apnea or thyroid issues before deciding on a long-term treatment plan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Pulmonary Vein Antral Isolation and Nonpulmonary Vein Trigger Ablation Are Sufficient to Achieve Favorable Long-Term Outcomes Including Transformation to Paroxysmal Arrhythmias in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation.

    Liang JJ, Elafros MA, Muser D, et al.

    Circulation. Arrhythmia and electrophysiology 2016; (9(11)).

    PMID: 27784738
  2. 2

    [The 2024 ESC guidelines for management of atrial fibrillation : AF-CARE as new credo].

    Wolfes J, Eckardt L

    Herzschrittmachertherapie & Elektrophysiologie 2024; (35(4)):318-323 doi:10.1007/s00399-024-01053-7.

    PMID: 39538025
  3. 3

    CLOSE-Guided Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation: 1-Year Outcome.

    Taghji P, Deharo JC, Amraoui S, Bun SS

    Journal of clinical medicine 2023; (12(14)) doi:10.3390/jcm12144698.

    PMID: 37510813
  4. 4

    Catheter Ablation of Long-standing Persistent Atrial Fibrillation: a Reckless Challenge or a Way to Real Cure?

    Pak HN

    Korean circulation journal 2019; (49(2)):134-145 doi:10.4070/kcj.2018.0418.

    PMID: 30693681
  5. 5

    Intraprocedural atrial flutter transition predicts arrhythmia-free survival after "2C3L Plus" ablation for long-standing persistent atrial fibrillation.

    Liu T, Han K, Yang Y, Long D

    Frontiers in cardiovascular medicine 2026; (13()):1781094 doi:10.3389/fcvm.2026.1781094.

    PMID: 42111139
  6. 6

    [Efficiency of the Decision-Making Module in the Personalized Choice of an Anticoagulant].

    Gorbunova EV, Duvanova SP, Filimonov KM, et al.

    Kardiologiia 2021; (61(3)):18-22 doi:10.18087/cardio.2021.3.n1511.

    PMID: 33849414
  7. 7

    Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy.

    Murakata Y, Yamagami F, Murakoshi N, et al.

    Frontiers in cardiovascular medicine 2022; (9()):1075358 doi:10.3389/fcvm.2022.1075358.

    PMID: 36741841
  8. 8

    Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure.

    Denham NC, Pearman CM, Caldwell JL, et al.

    Frontiers in physiology 2018; (9()):1380 doi:10.3389/fphys.2018.01380.

    PMID: 30337881
  9. 9

    Association between left atrial slow conduction velocity and recurrence of atrial fibrillation: a prospective study based on high-density mapping.

    Qi D, Guan X, Liu X, et al.

    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2025; (68(9)):1813-1822 doi:10.1007/s10840-025-02052-5.

    PMID: 40304954
  10. 10

    A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation.

    Sygitowicz G, Maciejak-Jastrzębska A, Sitkiewicz D

    Journal of clinical medicine 2021; (10(19)) doi:10.3390/jcm10194430.

    PMID: 34640448
  11. 11

    Inflammatory pathways in atrial fibrillation: mechanisms and novel therapeutic targets.

    Lu YY, Chen YJ, Lip GYH, Chen SA

    European heart journal 2026; (47(23)):2894-2912 doi:10.1093/eurheartj/ehag131.

    PMID: 41879137
  12. 12

    Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.

    Sposato LA, Cipriano LE, Saposnik G, et al.

    The Lancet. Neurology 2015; (14(4)):377-87.

    PMID: 25748102
  13. 13

    Comparison of Arrhythmia Detection by 24-Hour Holter and 14-Day Continuous Electrocardiography Patch Monitoring.

    Chua SK, Chen LC, Lien LM, et al.

    Acta Cardiologica Sinica 2020; (36(3)):251-259 doi:10.6515/ACS.202005_36(3).20190903A.

    PMID: 32425440
  14. 14

    Diagnostic Yield, Outcomes, and Resource Utilization With Different Ambulatory Electrocardiographic Monitoring Strategies.

    Gupta N, Yang J, Reynolds K, et al.

    The American journal of cardiology 2022; (166()):38-44 doi:10.1016/j.amjcard.2021.11.027.

    PMID: 34953575
  15. 15

    Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial.

    Buck BH, Hill MD, Quinn FR, et al.

    JAMA 2021; (325(21)):2160-2168 doi:10.1001/jama.2021.6128.

    PMID: 34061146
  16. 16

    Detection of Subclinical Atrial Fibrillation in High-Risk Patients Using an Insertable Cardiac Monitor.

    Philippsen TJ, Christensen LS, Hansen MG, et al.

    JACC. Clinical electrophysiology 2017; (3(13)):1557-1564 doi:10.1016/j.jacep.2017.06.020.

    PMID: 29759838
  17. 17

    Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.

    Lubitz SA, Faranesh AZ, Selvaggi C, et al.

    Circulation 2022; (146(19)):1415-1424 doi:10.1161/CIRCULATIONAHA.122.060291.

    PMID: 36148649
  18. 18

    NICE atrial fibrillation guideline snubs wearable technology: a missed opportunity?

    Briosa e Gala A, Pope MT, Leo M, et al.

    Clinical medicine (London, England) 2022; (22(1)):77-82 doi:10.7861/clinmed.2021-0436.

    PMID: 35078798
  19. 19

    [European Society of Cardiology (ESC) guidelines on atrial fibrillation 2024 : What is new and what is important?]

    Hättasch R, Tscholl V, Hindricks G, Dagres N

    Herz 2025; (50(1)):3-7 doi:10.1007/s00059-024-05287-6.

    PMID: 39604644
  20. 20

    Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.

    Inciardi RM, Giugliano RP, Claggett B, et al.

    European journal of heart failure 2019; (21(12)):1571-1579 doi:10.1002/ejhf.1606.

    PMID: 31777160
  21. 21

    Influence of Chronic Obstructive Pulmonary Disease on Atrial Mechanics by Speckle Tracking Echocardiography in Patients With Atrial Fibrillation.

    Goedemans L, Leung M, van der Bijl P, et al.

    The American journal of cardiology 2021; (143()):60-66 doi:10.1016/j.amjcard.2020.12.036.

    PMID: 33359195
  22. 22

    Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

    Larsson SC, Allara E, Mason AM, et al.

    Circulation. Genomic and precision medicine 2019; (12(3)):e002468 doi:10.1161/CIRCGEN.118.002468.

    PMID: 30702347
  23. 23

    The Liver-Heart Connection: A Literature Review of Liver Disease as a Risk Factor for Atrial Fibrillation.

    Obi MF, Reinberg Palmar A, Namireddy V, et al.

    Cureus 2023; (15(5)):e38536 doi:10.7759/cureus.38536.

    PMID: 37288203
  24. 24

    Clinical screening tools for obstructive sleep apnea in a population with atrial fibrillation: a diagnostic accuracy trial.

    Mohammadieh AM, Sutherland K, Kanagaratnam LB, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(5)):1015-1024 doi:10.5664/jcsm.9098.

    PMID: 33560210
  25. 25

    Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review.

    Linz D, McEvoy RD, Cowie MR, et al.

    JAMA cardiology 2018; (3(6)):532-540 doi:10.1001/jamacardio.2018.0095.

    PMID: 29541763

This page is for informational purposes only and does not constitute medical advice. Your cardiology team can interpret your test results and recommend care for your specific situation.

Get notified when new evidence is published on atrial fibrillation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.